A COMPARATIVE STUDY OF THE EFFECTS OF TIBOLON AND HORMONE REPLACEMENT THERAPY (HRT) ON THE PREDICTIVE MARKERS OF CARDIOVASCULAR DISEASE IN POST MENOPAUSAL PATIENTS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ZIAEI SAEIDEH; VAKILINIA T.; FAGHIHZADEH S.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: DANESHVAR MEDICINE Year:2009 | Volume:16 | Issue:82 Page(s): 21-26

Download Full-Text

Persian Verion

View:

760

Download:

Cites:

Information Journal Paper

Title

A COMPARATIVE STUDY OF THE EFFECTS OF TIBOLON AND HORMONE REPLACEMENT THERAPY (HRT) ON THE PREDICTIVE MARKERS OF CARDIOVASCULAR DISEASE IN POST MENOPAUSAL PATIENTS

Author(s)

ZIAEI SAEIDEH | VAKILINIA T. | FAGHIHZADEH S. | Issue Writer Certificate

Keywords

TIBOLONQ3

HRTQ4

CARDIOVASCULAR MARKERSQ3

MENOPAUSEQ2

Abstract

Background: MENOPAUSE is the consistent pause of menstrual blood for one year period. It is physiologically related to lesser estrogen secretion, which develops cardiovascular disease in women above 50 and is the leading cause of death (more than 50%) among them.TIBOLON is a tissue specific composition with low estrogenic, progestagic and androgenic activities. These qualities have desirable effect on MENOPAUSE symptoms. This study investigated the TIBOLON effect and compared it to estrogen and progestron (hormone replacement therapy), as predictive markers of cardiovascular diseases in postmenopausal women in Iran.Materials and Methods: This is a clinical- analytical trial study. 140 women in their MENOPAUSE period (Aged 45-60) were randomly selected and placed in three study groups. The filled the consent form and paid no expenses. The first group received 2.5 mg of TIBOLON pill plus calcium D (500 mg + 200 IU). These cond group received estrogen congoga pill (0.625 mg) plus 2.5 mg medroxi progestron state along with calcium D (500 mg + 200 IU). The third group only received daily calcium D (500 mg + 200 IU). CRP serum level and plasma lipids were compared to each other at the beginning of the study and six months after the treatment.Results: In the first group, HDL, LDL cholestrole and total cholesterol, triglicride were significantly reduced compared to prior to the treatment (P< 0.05).Both methods of TIBOLON and HRT increased CRP serum level. However, the increase was more significant in HRT group (P< 0.05). In the second group, the HDL cholesterol and total cholesterol decreased. Nevertheless, triglicride and CPR significantly increased (P< 0.05). On the other hand, LDL and total cholesterol and triglicride decreased significantly (P< 0.05). The intergroup comparison revealed that Tibilon had decreased triglicride, while, HRT increased it compared to the calcium group. Moreover it had decreased HDL, whereas HRT increased it compared to the control group in addition both TIBOLON and HRT decreased LDL but increased CRP, similarly. The increase being more significant in the HRT group.Conclusion: Since TIBOLON has the same effect as HRT on the decrease of LDL and triglicride serum levels, but less increase at CRP level, it can be an adequate substitute for HRT to eliminate the complications of MENOPAUSE such as cardiovascular diseases.

Cites

No record.

References

No record.

Cite

APA: Copy

ZIAEI, SAEIDEH, VAKILINIA, T., & FAGHIHZADEH, S.. (2009). A COMPARATIVE STUDY OF THE EFFECTS OF TIBOLON AND HORMONE REPLACEMENT THERAPY (HRT) ON THE PREDICTIVE MARKERS OF CARDIOVASCULAR DISEASE IN POST MENOPAUSAL PATIENTS. DANESHVAR MEDICINE, 16(82), 21-26. SID. https://sid.ir/paper/30853/en

Vancouver: Copy

ZIAEI SAEIDEH, VAKILINIA T., FAGHIHZADEH S.. A COMPARATIVE STUDY OF THE EFFECTS OF TIBOLON AND HORMONE REPLACEMENT THERAPY (HRT) ON THE PREDICTIVE MARKERS OF CARDIOVASCULAR DISEASE IN POST MENOPAUSAL PATIENTS. DANESHVAR MEDICINE[Internet]. 2009;16(82):21-26. Available from: https://sid.ir/paper/30853/en

IEEE: Copy

SAEIDEH ZIAEI, T. VAKILINIA, and S. FAGHIHZADEH, “A COMPARATIVE STUDY OF THE EFFECTS OF TIBOLON AND HORMONE REPLACEMENT THERAPY (HRT) ON THE PREDICTIVE MARKERS OF CARDIOVASCULAR DISEASE IN POST MENOPAUSAL PATIENTS,” DANESHVAR MEDICINE, vol. 16, no. 82, pp. 21–26, 2009, [Online]. Available: https://sid.ir/paper/30853/en

Related Journal Papers